These challenges directly impact timelines, costs, and study outcomes.

In our latest article, we break down:
✔ Key patient recruitment challenges
✔ Practical strategies to overcome them
✔ How CROs can accelerate enrollment and improve retention
#PatientRecruitment #ClinicalTrials #ClinicalResearch #CRO 
#ClinicalTrialRecruitment #PatientEnrollment #ClinicalOperations 
#PatientRetention #RecruitmentChallenges #ClinicalResearchIndia

https://genelifecr.blogspot.com/2026/04/patient-recruitment-challenges-in.html

This brief examines how a longstanding Paxil study was flagged with an expression of concern, highlighting vulnerabilities in research reporting and data transparency. For mental health professionals, the emphasis on scrutinizing source validity, especially when guiding prescribing decisions for youth, is a key reminder of the ongoing need for critical appraisal of the literature and caution in interpreting pivotal trials.

Article Title: STAT+: Flawed study on the antidepressant Paxil came with a cautionary note — if you knew how to find it

Link to STAT NEWS Mental Health Article: https://www.statnews.com/pharmalot/2026/04/15/paxil-adolescent-antidepressant-pivotal-study-expression-concern/?utm_campaign=rss

STAT+: Flawed study on the antidepressant Paxil came with a cautionary note — if you knew how to find it<br>
https://www.statnews.com/pharmalot/2026/04/15/paxil-adolescent-antidepressant-pivotal-study-expression-concern/?utm_campaign=rss<br>
<p>File this under &#x201C;hiding in plain sight.&#x201D;</p>

<p>Last fall, the Journal of the American Academy of Child &amp; Adolescent Psychiatry issued a so-called <a href="https://www.sciencedirect.com/science/article/pii/S0890856725021070">expression of concern</a> about a controversial <a href="https://www.jaacap.org/article/S0890-8567(09)60309-9/abstract">study</a> that was published in 2001 about the widely prescribed antidepressant known as Paxil.</p>

<p>Such a step is taken when a study may have errors or include unreliable information. The notice, which <a href="https://www.statnews.com/pharmalot/2025/08/25/antidepressant-paxil-gsk-medical-journal-children-adolescents-depression-ghostwriting-retraction/">followed a request for a retraction</a>, indicated that a review was underway. Meanwhile, it served as a warning, of sorts, to health care providers who might consult the study when deciding whether to prescribe the medicine.</p><p><a href="https://www.statnews.com/pharmalot/2026/04/15/paxil-adolescent-antidepressant-pivotal-study-expression-concern/?utm_campaign=rss">Continue to STAT+ to read the full story&hellip;</a></p><br>
via STAT Mental Health: News on Research, Treatment, Public Policy https://www.statnews.com/topic/mental-health/<br>
April 15, 2026 at 04:30AM

Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.

#psychotherapy #mentalhealth #researchethics #clinicaltrials #prescribingguidelines

Clinical trial: Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate Safety, Tolerability, PK and PD of Antisense Oligonucleotide AMX0114 Administered to Adult Participants With Amyotrophic Lateral Sclerosis

https://clinicaltrials.gov/study/NCT06665165?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_6842

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

We’ve updated our website to better reflect our integrated clinical research capabilities.
Genelife Clinical Research now brings together Clinical Trials, Real-World Evidence, and Healthcare Market Research within a unified CRO framework, supporting product development across the lifecycle.
Explore our updated website to learn more about our approach and expertise:
#clinicalresearch #CRO #clinicaltrials #realworldevidence #RWE #MarketResearch #genelife #GeneLife

https://www.genelifecr.com/

The article examines whether psychedelic therapy and traditional antidepressants yield similar improvements in depression when both are studied under open-label conditions, suggesting that study design and expectations may account for some previously observed advantages of psychedelics. It also discusses methodological issues like functional unblinding and the implications for interpreting treatment effectiveness.

This topic is of interest to psychology readers because it highlights how study design, expectations, and placebo-related factors can influence observed treatment outcomes, underscoring the complexity of evaluating novel therapies within mental health research.

Article Title: Psychedelic therapy and traditional antidepressants show similar results under open-label conditions

Link to PsyPost Article: https://www.psypost dot org/psychedelic-therapy-and-traditional-antidepressants-show-similar-results-under-open-label-conditions/

Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.

#psychedelictherapy #depressionresearch #clinicaltrials #openlabel #blindingissues

Clinical trial: Evaluation of the Effects of Laughter Yoga on Pain Intensity, Stress, and Beta-endorphin Levels in Patients With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07524231?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20406

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy Volunteers

https://clinicaltrials.gov/study/NCT07521982?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20407

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: An Open-Label Clinical Study to Evaluate the Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

https://clinicaltrials.gov/study/NCT07526493?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20408

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Influance of Walking Fatigability on Spatiotemporal Gait Parameters and Risk of Falling in Patients With Multiple Scalerosis

https://clinicaltrials.gov/study/NCT07524556?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20409

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology